Background and Purpose-Silent brain infarction (SBI) on MRI is common in elderly people, and recent studies have demonstrated that SBI increases the risk of progression to clinically apparent stroke and cognitive decline. Therefore, an early and accurate detection of SBI and a search for potential treatable risk factors may have a significant impact on public health. Methods-Community-dwelling elderly people aged Ն66 years who participated in the present study (nϭ153) underwent brain MRI and standardized physical and neuropsychological examinations as well as blood biochemistry determinations, including total plasma homocysteine (pHcy), renal function, vitamin status, and polymorphisms of the methylenetetrahydrofolate reductase gene. Results-SBI was found in 24.8% of the participants. In the univariate analysis, the pHcy levels in subjects with SBI (13.6Ϯ4.1 mol/L) were significantly higher (Pϭ0.0004) than those in subjects without SBI (11.0Ϯ3.3 mol/L). When pHcy levels were stratified into high (Ն15.1 mmol/L), moderate (11.6 to 15.0 mmol/L), and low (Յ11.5 mmol/L) groups, age (PϽ0.0001), male sex (PϽ0.0001), the habits of cigarette smoking (PϽ0.0001) and of alcohol consumption (Pϭ0.0002), and folate levels (Pϭ0.01) were significantly associated with an elevation of pHcy levels. The elevated pHcy levels were significantly associated with SBI after individual adjustment for age, sex, hypertension, renal function, and the habits of smoking and alcohol consumption. Conclusions-pHcy level is associated with age and nutritional and other lifestyle factors, and it contributes to a risk for SBI.
A ccording to a clinicopathological study by Fisher, 1 88 (77.2%) of 114 patients with at least 1 lacunar stroke lesion were free of either clinical history of stroke or a neurological deficit during life. Most of these lacunar lesions were reported to be located in deep brain structures, including basal ganglia, pons, and subcortical white matter. Moreover, recent advances in neuroimaging techniques have enabled us to detect the presence and extent of silent brain infarction (SBI) more accurately and easily. Indeed, because high-resolution MRI has become widely used as a part of routine examination of the brain in Japan, SBI has become a more recognizable condition that draws unique attention as an important prodromal stage or as a risk for progression into symptomatic stroke and cognitive impairment in the elderly population. Hougaku et al 2 detected SBI in 49 (42%) of 117 elderly people in outpatient clinical settings who had at least 1 stroke risk factor but did not have a history of clinical stroke. Shinkawa et al 3 found SBI in 125 (12.9%) of 966 subjects who had undergone autopsy in a community-based study at Hisayama. Furthermore, Kobayashi et al 4 demonstrated in a prospective study that elderly subjects with SBI were 10 times more likely to develop clinical stroke than were those without SBI. The Cardiovascular Health Study demonstrated a strong association between SBI and impaired cognition. 5 Although it is well documented that many conditions, including age, hypertension, atrial fibrillation, and hypercoagulability, confer a strong risk of SBI, 3-7 subjects without such traditional risk factors occasionally develop SBI. Therefore, it is likely that there may be other undefined risk factors that might operate in the pathogenesis of SBI.
For the past decade, mildly elevated plasma homocysteine (pHcy) levels have been recognized as a risk factor for a number of occlusive vascular diseases (see review 8 and citations herein for more details). Furthermore, recent studies have demonstrated that elevated pHcy levels are also associated with Alzheimer's disease, with no apparent macroscopic lesions, suggesting that pHcy-induced microvascular lesions may play a role in the pathogenesis of Alzheimer's disease. 9 Although the homozygous state of a common mutation (C677T) in the methylenetetrahydrofolate reductase (MTHFR) gene is reported to be responsible for the thermolabile phenotype and is associated with decreased MTHFR activity and elevated pHcy levels, 10 little is known regarding the confounding caused by factors associated with hyperhomocysteinemia, and its relevance to SBI has never been studied. In the present study, we conducted a populationbased, cross-sectional, case-control analysis of SBI to test the hypothesis that an elevated pHcy increases a risk for SBI. We also analyzed vitamin status and other lifestyle profiles that might be potentially related to pHcy levels.
Subjects and Methods

Subjects
We examined 153 community-dwelling elderly people (30 men and 123 women, aged 76.7Ϯ5.3 years, range 66 to 88 years) who were living in the rural community of Sefuri Village, Saga, Japan. All participants were healthy volunteers and were living independently at home without apparent history of stroke and dementia. Informed consent was given by each participant, and our study protocol was approved by the ethical review committee at Tohoku University School of Medicine. All participants underwent standardized physical and neuropsychological examinations. Cognitive functions were assessed and evaluated by Mini-Mental State Examination. Those who had cardioembolic risk factors, including atrial fibrillation, valvular heart disease, and myocardial infarction, were excluded. Subjects were diagnosed as having hypertension if there was a history of blood pressure recordings Ͼ160/95 mm Hg or if the subject was being treated by antihypertensive drugs. Habitual alcohol consumption was considered present if there was a history of alcohol intake for Ն5 days a week. MRI was performed on a 1.0-T superconducting magnet. Transverse T1-weighted, T2-weighted, and fluid-attenuated inversion recovery (FLAIR) images were obtained with a slice thickness of 8 mm. The diagnosis of SBI was made as follows: (1) spotty areas Ն3 mm in diameter showing high intensity in the T2 and FLAIR images and low intensity in the T1 image, 11 (2) lack of neurological signs and/or symptoms that can be explained by the MRI lesions, and (3) no medical history of clinical stroke. Very small punctate hyperintensity lesions (1 to 2 mm in diameter) were more likely to represent dilated perivascular spaces and were not considered in the present study. MRI findings were evaluated by 2 independent researchers in a blinded manner. The diagnosis of SBI was made when the researchers agreed with each other. Those participants without evidence of SBI on MRI were selected as controls. All other details have been described in our earlier report. 12 
Total pHcy, Blood Biochemistry, and Genotyping of MTHFR Alleles
Peripheral blood samples were taken in the morning after the subjects had fasted for at least 12 hours. After centrifugation at 2000 rpm for 15 minutes, plasma samples were kept at Ϫ20°C until analysis. Predicted creatinine clearance was calculated as an index of renal function according to the formula described by Cockcroft and Gault. 13 Total pHcy levels were measured by a sensitive enzyme conversion immunoassay. 14 Serum vitamin B 12 and folate levels were determined by use of a chemiluminescence assay. Subjects who showed extremely high levels of vitamin B 12 (Ͼ1500 pg/mL) or folate (Ͼ20 ng/mL) were excluded from subsequent statistical analysis. Genomic DNA was extracted from peripheral leukocytes by a DNA extraction kit (DNA Extractor WB kit, Wako Chemicals). The C677T polymorphisms of the MTHFR gene were determined according to the methods described by Frosst et al 10 in a blind manner of diagnosis.
Statistical Analysis
Statistical analyses were carried out with the SPSS software package, version 10.0. Logistic regression models were used to estimate the odds ratio (95% CI) of SBI for tertiles of pHcy levels, ie, Յ11.5, 11.6 to 15.0, and Ն15.1 mmol/L, to assess the relation of pHcy levels to other relevant risk factors of SBI. Two dummy variables representing higher pHcy groups (11.6 to 15.0 and Ն15.1) were compared with the lower pHcy group (Յ11.5).
Results
Of the 153 eligible subjects, 38 (24.8%) met the criteria for a diagnosis of SBI. Most lesions were Ͻ10 mm in diameter and were usually located in subcortical white matter or basal ganglia. The meanϮSD of the Mini-Mental State Examination score was 28.5Ϯ3.4 points in the SBI-negative group and 25.9Ϯ3.8 points in the SBI-positive group (PϽ0.001). Table 1 showed distribution of clinical or other characteristics according to the presence or absence of SBI. This univariate analysis demonstrated that the pHcy levels in the SBI group were significantly higher than those in the group without SBI (13.6Ϯ4.1 versus 11.0Ϯ3.3 mol/L, Pϭ0.0004). Furthermore, male sex (PϽ0.0001), age (Pϭ0.0004), hypertension (Pϭ0.0046), habits of smoking (PϽ0.0001) and alcohol consumption (Pϭ0.0003), and folate (Pϭ0.012) and vitamin B 12 (Pϭ0.014) levels were also significantly associated with SBI. By contrast, there was no significant association between SBI and diabetes mellitus, body mass index, packed cell volume, total cholesterol levels, HDL cholesterol levels, and MTHFR polymorphism in the univariate analysis.
As shown in Table 2 , when pHcy levels were stratified into high (Ն15.1 mmol/L), moderate (11.6 to 15.0 mmol/L), and low (Յ11.5 mmol/L) groups, age (PϽ0.0001), male sex (PϽ0.0001), habits of cigarette smoking (PϽ0.0001) and alcohol consumption (Pϭ0.0002), and folate levels (Pϭ0.01) were significantly associated with elevation of pHcy levels. Blood pressure tended to be higher as pHcy levels increased, but it did not reach a statistical significance (Pϭ0.06). The pHcy levels did not differ significantly between different MTHFR genotypes (data not shown). Vitamin B 12 and folate levels did not differ significantly between different MTHFR genotypes (data not shown). As shown in Table 3 , the odds ratio (95% CI) of SBI was 4.5 (1.5 to 13.5) in the high group and 2.8 (1.1 to 7.0) in the moderate group compared with the low group after adjustment for age (Pϭ0.01, model A). After adjustment for sex, the odds ratio (95% CI) was 4.7 (1.6 to 13.8) in the high group and 2.6 (1.0 to 6.6) in the moderate group (Pϭ0.01, model B). Furthermore, after adjustment for hypertension and renal function, the odds ratio (95% CI) was 6.0 (2.1 to 16.9) in the high group and 3.2 (1.3 to 8.1) in the moderate group (Pϭ0.001, model C). Finally, after adjustment for current habits of smoking and alcohol consumption, the odds ratio (95% CI) was 4.5 (1.5 to 13.3) in the high group and 2.3 (0.9 to 6.1) in the moderate group (Pϭ0.02, model D).
Discussion
The prevalence of SBI was 38 (24.8%) of 153 in the present study. The prevalence was similar to that (28%) reported in a population-based study of 3647 living men and women aged Ն65 years who underwent MRI in the Cardiovascular Health Study, 5 whereas it was higher than that (12.9%) reported in a community-based autopsy series. 3 The prevalence of SBI may vary with different age, underlying risk factors, imaging tech-
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niques, and research protocols. [2] [3] [4] [5] The strengths of the present study are as follows: We have examined MRI abnormalities of SBI and compared them with a number of variables, including age, sex, disease status, and lifestyle profiles as well as pHcy levels and other biochemical determinations of renal function and vitamin status. We have found that mild hyperhomocysteinemia is associated with an increased a risk for SBI after age, sex, hypertension, renal function, and habits of smoking/alcohol consumption were controlled individually. There was a graded relationship between pHcy levels and the risk of SBI without an obvious threshold level. Despite a small sample size in the present study, the present results confirmed earlier reports that age, serum creatinine level, and a lifestyle profile characterized by an excessive alcohol consumption and low vitamin intake strongly contribute to the elevation of pHcy levels. 15, 16 By contrast, we found no association between the MTHFR polymorphism and pHcy levels and between the MTHFR polymorphism and SBI. These findings are in agreement with other recent studies that the MTHFR polymorphism does not appear to be associated with an increased risk of stroke or other vascular diseases. 17, 18 The exact reason for the negative association is unclear at the present time. One possibility may be that decreased and thermolabile MTHFR activity can be well counteracted by an adequate intake of dietary vitamins in the majority of the homozygous subjects, thus leading to unremarkable pHcy levels as a function of the MTHFR polymorphism. Alternatively, it can be argued that there remains a possibility of interactions with other potentially important genes, such as the G20210A prothrombin gene mutation 19 (authors' unpublished data). It is not known whether extracranial large arteries or intracranial microvessels are more susceptible to pHcy levels. Hougaku et al 2 demonstrated that asymptomatic carotid lesions were closely related to the appearance of SBI. In contrast, Faßbender et al 20 described surprisingly high concentrations of pHcy in patients with cerebral microangiopathy but not in patients with cerebral large-vessel disease.
Regardless of the sites and mechanism by which elevated pHcy generates or promotes atherosclerosis, the present study indicates that mild hyperhomocysteinemia can be treatable and normalized irrespective of the MTHFR genotype by either an adequate supplementation of vitamins or an appropriate intervention of lifestyle or a combination of both in elderly people. Indeed, a dietary supplementation with a moderate dose of folate is reported to reduce pHcy levels. 21, 22 Furthermore, Petersen and Spence 23 have demonstrated that a cocktail of folate, vitamin B 6 , and vitamin B 12 that was aimed at lowering pHcy levels attenuates the progression of carotid plaque area in patients with mild to moderate hyperhomocysteinemia. Although most of the subjects examined in the present study were cognitively normal and did not reach levels that fulfill the criteria for the diagnosis of dementia, the presence of SBI appeared to have a mild effect on cognitive function. Therefore, a reduction of pHcy levels may have a significant impact in reducing the risk of SBI and preventing the progression into clinical stroke, vascular dementia, or both. Prospective randomized trials assessing the effectiveness of homocysteine-lowering therapy in patients with SBI are needed. 
